急性冠状动脉综合征的降脂治疗 - Suppr | 超能文献

Lipid-lowering therapy in acute coronary syndromes.

作者信息

Sacks F M

出版信息

JAMA. 2001 Apr 4;285(13):1758-60. doi: 10.1001/jama.285.13.1758.

DOI:10.1001/jama.285.13.1758

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Lipid-lowering therapy in acute coronary syndromes.急性冠状动脉综合征的降脂治疗

JAMA. 2001 Apr 4;285(13):1758-60. doi: 10.1001/jama.285.13.1758.

2

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.阿托伐他汀对急性冠状动脉综合征早期再发缺血事件的影响：MIRACL研究：一项随机对照试验

JAMA. 2001 Apr 4;285(13):1711-8. doi: 10.1001/jama.285.13.1711.

3

Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?Cochrane 专栏：急性冠状动脉综合征的早期他汀类药物治疗——临床益处何在？

Heart. 2016 May;102(9):653-4. doi: 10.1136/heartjnl-2015-307781. Epub 2016 Feb 23.

4

Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.阿托伐他汀（80毫克）对不稳定型心绞痛和非Q波急性心肌梗死的抗炎作用。

Am J Cardiol. 2003 Aug 1;92(3):298-301. doi: 10.1016/s0002-9149(03)00630-1.

5

Intensive versus moderate lipid lowering with statins in acute coronary syndromes.他汀类药物强化降脂与中度降脂治疗急性冠状动脉综合征的比较。

Curr Atheroscler Rep. 2005 Mar;7(2):85-6.

6

Can early treatment with atorvastatin (Lipitor) improve the outcome of patients with acute coronary syndromes?早期使用阿托伐他汀（立普妥）治疗能否改善急性冠脉综合征患者的预后？

J Fam Pract. 2001 Jul;50(7):572.

7

Routine statin treatment after acute coronary syndromes?急性冠状动脉综合征后的常规他汀类药物治疗？

Am Heart J. 2002 Jun;143(6):940-2. doi: 10.1067/mhj.2002.122284.

8

Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.积极降低胆固醇减少心肌缺血（MIRACL）研究的原理与设计，该研究评估阿托伐他汀在不稳定型心绞痛和非Q波急性心肌梗死中的作用。

Am J Cardiol. 1998 Sep 1;82(5):703.

9

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.在MIRACL研究中，大剂量阿托伐他汀可增强急性冠脉综合征患者炎症标志物的下降。

Circulation. 2003 Sep 30;108(13):1560-6. doi: 10.1161/01.CIR.0000091404.09558.AF. Epub 2003 Sep 15.

10

What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?

Am J Cardiol. 2001 Oct 11;88(7B):7J-16J. doi: 10.1016/s0002-9149(01)01921-x.

引用本文的文献

1

Therapy to reduce risk of coronary heart disease.降低冠心病风险的治疗方法。

Clin Cardiol. 2003 Jan;26(1):2-8. doi: 10.1002/clc.4960260103.

2

The myocardial ischemia reduction with aggressive cholesterol lowering study.积极降低胆固醇减少心肌缺血研究

Curr Cardiol Rep. 2002 Nov;4(6):485.

3

Lipid-lowering therapies in the management of acute coronary syndromes.急性冠状动脉综合征管理中的降脂治疗

Curr Cardiol Rep. 2002 Jul;4(4):320-6. doi: 10.1007/s11886-002-0068-7.